BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22071889)

  • 1. Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.
    Jacquemin V; Rieunier G; Jacob S; Bellanger D; d'Enghien CD; Laugé A; Stoppa-Lyonnet D; Stern MH
    Eur J Hum Genet; 2012 Mar; 20(3):305-12. PubMed ID: 22071889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.
    Mitui M; Nahas SA; Du LT; Yang Z; Lai CH; Nakamura K; Arroyo S; Scott S; Purayidom A; Concannon P; Lavin M; Gatti RA
    Hum Mutat; 2009 Jan; 30(1):12-21. PubMed ID: 18634022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New mutations in the ATM gene and clinical data of 25 AT patients.
    Demuth I; Dutrannoy V; Marques W; Neitzel H; Schindler D; Dimova PS; Chrzanowska KH; Bojinova V; Gregorek H; Graul-Neumann LM; von Moers A; Schulze I; Nicke M; Bora E; Cankaya T; Oláh É; Kiss C; Bessenyei B; Szakszon K; Gruber-Sedlmayr U; Kroisel PM; Sodia S; Goecke TO; Dörk T; Digweed M; Sperling K; de Sá J; Lourenco CM; Varon R
    Neurogenetics; 2011 Nov; 12(4):273-82. PubMed ID: 21965147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
    Jiang H; Tang B; Xia K; Hu Z; Shen L; Tang J; Zhao G; Zhang Y; Cai F; Pan Q; Long Z; Wang G; Dai H
    J Neurol Sci; 2006 Feb; 241(1-2):1-6. PubMed ID: 16380133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder.
    Delia D; Piane M; Buscemi G; Savio C; Palmeri S; Lulli P; Carlessi L; Fontanella E; Chessa L
    Hum Mol Genet; 2004 Sep; 13(18):2155-63. PubMed ID: 15269180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
    Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
    Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.
    Prodosmo A; De Amicis A; Nisticò C; Gabriele M; Di Rocco G; Monteonofrio L; Piane M; Cundari E; Chessa L; Soddu S
    J Clin Invest; 2013 Mar; 123(3):1335-42. PubMed ID: 23454770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein.
    Iwahori S; Shirata N; Kawaguchi Y; Weller SK; Sato Y; Kudoh A; Nakayama S; Isomura H; Tsurumi T
    J Virol; 2007 Sep; 81(18):9653-64. PubMed ID: 17609267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.
    Staples ER; McDermott EM; Reiman A; Byrd PJ; Ritchie S; Taylor AM; Davies EG
    Clin Exp Immunol; 2008 Aug; 153(2):214-20. PubMed ID: 18505428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM and the molecular pathogenesis of ataxia telangiectasia.
    McKinnon PJ
    Annu Rev Pathol; 2012; 7():303-21. PubMed ID: 22035194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NBS1-ATM connection revisited.
    Difilippantonio S; Nussenzweig A
    Cell Cycle; 2007 Oct; 6(19):2366-70. PubMed ID: 17881893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in String/CDC25 inhibit cell cycle re-entry and neurodegeneration in a Drosophila model of Ataxia telangiectasia.
    Rimkus SA; Katzenberger RJ; Trinh AT; Dodson GE; Tibbetts RS; Wassarman DA
    Genes Dev; 2008 May; 22(9):1205-20. PubMed ID: 18408079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype.
    Babaei M; Mitui M; Olson ER; Gatti RA
    Hum Genet; 2005 Jul; 117(2-3):101-6. PubMed ID: 15843990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1.
    Balmus G; Zhu M; Mukherjee S; Lyndaker AM; Hume KR; Lee J; Riccio ML; Reeves AP; Sutter NB; Noden DM; Peters RM; Weiss RS
    Hum Mol Genet; 2012 Aug; 21(15):3408-20. PubMed ID: 22575700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients.
    Soukupova J; Pohlreich P; Seemanova E
    Neuromolecular Med; 2011 Sep; 13(3):204-11. PubMed ID: 21833744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
    Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
    J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ATM gene mutations in 66 ataxia telangiectasia families.
    Sandoval N; Platzer M; Rosenthal A; Dörk T; Bendix R; Skawran B; Stuhrmann M; Wegner RD; Sperling K; Banin S; Shiloh Y; Baumer A; Bernthaler U; Sennefelder H; Brohm M; Weber BH; Schindler D
    Hum Mol Genet; 1999 Jan; 8(1):69-79. PubMed ID: 9887333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of ataxia telangiectasia and related diseases.
    Ball LG; Xiao W
    Acta Pharmacol Sin; 2005 Aug; 26(8):897-907. PubMed ID: 16038621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.
    Nakamura K; Du L; Tunuguntla R; Fike F; Cavalieri S; Morio T; Mizutani S; Brusco A; Gatti RA
    Hum Mutat; 2012 Jan; 33(1):198-208. PubMed ID: 22006793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five haplotypes account for fifty-five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: seven new mutations.
    Coutinho G; Mitui M; Campbell C; Costa Carvalho BT; Nahas S; Sun X; Huo Y; Lai CH; Thorstenson Y; Tanouye R; Raskin S; Kim CA; Llerena J; Gatti RA
    Am J Med Genet A; 2004 Apr; 126A(1):33-40. PubMed ID: 15039971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.